Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
23.26
-0.13 (-0.56%)
At close: Apr 16, 2026, 4:00 PM EDT
23.34
+0.08 (0.34%)
After-hours: Apr 16, 2026, 7:35 PM EDT
Immunome Market Cap
Immunome has a market cap or net worth of $2.63 billion as of April 16, 2026. Its market cap has increased by 383.45% in one year.
Market Cap
2.63B
Enterprise Value
1.99B
1-Year Change
383.45%
Ranking
Category
Stock Price
$23.26
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $2.63B, an increase of 2,262.38%. That is a compound annual growth rate of 76.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 2.63B | 11.04% |
| Dec 31, 2025 | 2.37B | 257.53% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradermics | 2.74B |
| Soleno Therapeutics | 2.72B |
| Zai Lab | 2.65B |
| Disc Medicine | 2.65B |
| Enliven Therapeutics | 2.65B |
| Celldex Therapeutics | 2.63B |
| ADMA Biologics | 2.52B |
| Kodiak Sciences | 2.52B |